Biomedcode Hellas s.a. - Priming Drugs for Success

biomedcode hellas sa is a highly innovative contract research organization (cro) that provides preclinical drug evaluation services to small and large pharmaceutical companies worldwide. using a unique collection of mouse models that mimic human inflammatory diseases, such as rheumatoid arthritis, intestinal inflammation, multiple sclerosis and others, biomedcode is offering a diverse array of state-of-the-art evaluation platforms ideal for the preclinical testing of therapeutics against human diseases. biomedcode’s human tnf transgenic models were instrumental in providing in vivo proof of principle on the role of deregulated tnf production underlying the development of chronic polyarthritis and for providing the preclinical rationale for the development of anti-tnf therapies for arthritis. biomedcode’s services combine scientific consulting and custom-tailored solutions towards optimizing the validation procedure of novel and biosimilar pharmaceuticals, as well as the development of